Key terms

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest BMY news

Today 7:40am ET Analysts Conflicted on These Healthcare Names: Viking Therapeutics (VKTX) and Bristol-Myers Squibb (BMY) by TipRanks Today 5:25am ET Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Laboratory (LH) and Bristol-Myers Squibb (BMY) by TipRanks Today 5:19am ET Bristol-Myers Squibb: Hold Rating Amid Mixed Performance and Future Revenue Concerns by TipRanks Today 4:47am ET Barclays Sticks to Their Hold Rating for Bristol-Myers Squibb (BMY) by TipRanks Yesterday 12:34pm ET Massive Job Cuts Send Bristol-Myers Squibb (NYSE:BMY) Stock Into Tailspin by TipRanks Yesterday 8:02am ET Bristol-Myers Squibb Q1 Earnings Call Strategy Insights by TipRanks Yesterday 7:32am ET Purple Biotech’s Phase 2 pancreatic cancer study selected as presentation by TipRanks Yesterday 7:04am ET Bristol Myers lowers FY24 adjusted EPS view to 40c-70c, consensus 65c by TipRanks Yesterday 7:02am ET Bristol Myers reports Q1 adjusted EPS ($4.40), consensus ($4.44) by TipRanks Yesterday 5:35am ET Bristol-Myers Squibb: A Hold Rating Amid Mixed Financial Outlook and Upcoming Strategic Updates by TipRanks Apr 24 8:25pm ET Notable companies reporting before tomorrow’s open by TipRanks Apr 24 2:22pm ET Notable companies reporting before tomorrow’s open by TipRanks Apr 22 7:18am ET Bristol Myers price target lowered to $52 from $55 at Cantor Fitzgerald by TipRanks Apr 22 7:02am ET Bristol Myers and Cellares sign $380M agreement for CAR T cell therapies by TipRanks Apr 22 7:01am ET Options Volatility and Implied Earnings Moves This Week, April 22 – April 26, 2024 by TipRanks Apr 18 6:18am ET Bristol Myers price target raised to $52 from $51 at Wells Fargo by TipRanks Apr 18 6:10am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Accolade (ACCD), Ultragenyx Pharmaceutical (RARE) and Bristol-Myers Squibb (BMY) by TipRanks Apr 12 6:00am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (BMY) and Roche Holding AG (OtherRHHVF) by TipRanks Apr 12 5:25am ET Bristol-Myers Squibb: A Buy Rating on Undervaluation and Promising Product Portfolio by TipRanks Apr 08 11:33am ET Bristol Myers: Krazati plus cetuximab showed ORR of 34%, PFS of 6.9 months by TipRanks Apr 08 5:47am ET Bristol-Myers Squibb’s Hold Rating: Balancing KarXT’s Efficacy and Safety with Financial Uncertainties by TipRanks Apr 07 6:44am ET Bristol Myers presents new data from Phase 3 EMERGENT program evaluating KarXT by TipRanks Apr 07 6:34am ET Bristol Myers presents new interim long-term efficacy data from EMERGENT-4 trial by TipRanks Apr 05 9:08am ET Bristol Myers, 2seventy Bio’s Abecma approved by U.S. FDA by TipRanks Apr 03 4:03pm ET Standard BioTools announces multi-year agreement with Bristol Myers by TipRanks Apr 03 5:56am ET Bristol Myers: European Commission expands approval of Reblozyl by TipRanks Apr 03 5:16am ET Wells Fargo Sticks to Its Hold Rating for Bristol-Myers Squibb (BMY) by TipRanks Apr 01 7:39am ET Zai Lab, Bristol Myers: Krazati confirmatory trial meets PFS primary endpoints by TipRanks Mar 31 5:25am ET Ex-Dividend Date Nearing for These 10 Stocks – Week of April 1, 2024 by TipRanks Mar 29 8:30am ET Bristol Myers ends collaboration agreement with Molecular Templates by TipRanks Mar 28 5:20pm ET Bristol Myers Squibb (NYSE:BMY) Slips after Disappointing Drug Trial by TipRanks Mar 28 4:15pm ET Bristol Myers says KRYSTAL-12 trial met primary endpoint in PFS by TipRanks
Apr 14 10:16am ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY by Newsfile Apr 11 9:10am ET Building a Better Future: Bristol Myers Squibb 2023 ESG Report by Accesswire Apr 08 7:00am ET Bristol Myers Squibb Releases 2023 ESG Report Demonstrating Progress and Setting New Long-Term Goals by Accesswire Apr 06 3:02pm ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY by Newsfile Apr 02 2:30pm ET Bristol Myers Squibb Releases 2023 Environmental, Social and Governance Report Demonstrating Progress and Setting New Long-Term Goals by Accesswire Mar 29 11:26am ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY by Newsfile Mar 29 9:45am ET Bristol Myers Squibb Expands Health Equity Grant Initiatives to Improve Health Outcomes by Accesswire Mar 21 1:28pm ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY by Newsfile Mar 14 8:15am ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY by Newsfile

BMY Financials

1-year income & revenue

Key terms

BMY Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

BMY Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Student demonstrators occupy the pro-Palestinian "Gaza Solidarity Encampment" on the West Lawn of Columbia University on April 24, 2024 in New York City.
Michael M. Santiago/Getty Images
What the pro-Palestinian protesters on college campuses actually want
People walk by the New York Stock Exchange (NYSE) on March 20, 2024 in New York City. The Dow was up slightly in late morning trading as traders analyze the Federal Reserve's latest decision on interest rates.
Spencer Platt/Getty Images
Stagflation fears just hit Wall Street. Now for the next crucial report on prices
Meta headquarters pictured on February 02, 2023 in Menlo Park, California.
Justin Sullivan/Getty Images
Meta’s stock plunges 15% on ‘aggressive’ AI spending plans
GettyImages-1159438448 copy.jpg
Lyndon Stratford/iStockphoto/Getty Images
Americans are falling behind on their payments